SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-048665
Filing Date
2012-08-29
Accepted
2012-08-29 16:01:52
Documents
3
Period of Report
2012-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v322656_8k.htm 8-K 15545
2 EXHIBIT 99.1 v322656_ex99-1.htm EX-99.1 8195
3 GRAPHIC logo.jpg GRAPHIC 5799
  Complete submission text file 0001144204-12-048665.txt   33184
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32715 | Film No.: 121063214
SIC: 2835 In Vitro & In Vivo Diagnostic Substances